𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mirtazapine reduces levodopa-induced dyskinesia

Book ID
120860072
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
120 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Levodopa-induced dyskinesia
Levodopa-induced dyskinesia
✍ Agid Yves πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 93 KB
Levodopa-induced dyskinesias
Levodopa-induced dyskinesias
✍ Giovanni Fabbrini; Jonathan M. Brotchie; Francisco Grandas; Masahiro Nomoto; Chr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Levodopa‐induced dyskinesias (LID) are common and difficult to treat. This review focuses on three issues related to LID: clinical features, classification and rating, pathophysiology and pathogenesis, and management. The three primary clinical syndromes are OFF‐period dystonia, peak‐do

Amantadine reduces levodopa-induced dysk
Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys
✍ Pierre J. Blanchet; Spyridon Konitsiotis; Thomas N. Chase πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 465 KB

The antidyskinetic potential of the glutamate NMDA receptor channel blocker amantadine was evaluated in four levodopa-primed parkinsonian monkeys using two different regimens (1.25 or 2.5 mg/kg administered subcutaneously twice daily for 3-6 days). When administered with a relatively low dose of lev